Business
Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2025
Accounts Receivable Decreased from $67.7M to $60.4M Improving Company Financial PositionPost-Quarter End, IKE Tech Filed PMTA with the FDA for its Age-Gating
About this update from Ispire Technology Inc.
[{"type":"text","content":"Accounts Receivable Decreased from $67.7M to $60.4M Improving Company Financial PositionPost-Quarter End, IKE Tech Filed PMTA with the FDA for its Age-Gating Joint Venture Component with IKELaunched SproutTM in Collaboration with Raw Garden, an Advanced All-In-One Cannabis Vapor Device Ensuring Purity and Safety \nLOS ANGELES, May 12, 2025 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ: ISPR) (\"Ispire,\" the \"Company,\" \"we,\" \"us,\" or \"our\"), an innovator in vaping technology and precision dosing, today reported financial results for the third quarter of fiscal 2025, for the three months ending March 31, 2025.\n\nFiscal Third Quarter 2025 Financial Results\nRevenue of $26.2 million versus $30.0 million for the third quarter of fiscal 2024.Gross profit of $4.8 million compared to $6.1 million for the third quarter of fiscal 2024.Gross margin of 18.2% compared to 20.4% for the third quarter of fiscal 2024.Total operating expenses of $15.4 million compared to $11.8 million for the third quarter of fiscal 2024.Net loss of ($10.9) million, compared to net loss of ($5.9) million in the third quarter of fiscal 2024.\"The progress the Company made during the third fiscal quarter demonstrates that we are delivering on our promises and executing on our strategic priorities to become a leading global provider of precision dosing vape technology,\" commented Michael Wang, Co-Chief Executive Officer of Ispire. \"We have made significant strides as we are transitioning our manufacturing to Malaysia, effectively de-risking our production strategy for the current geopolitical climate. During the third fiscal quarter, in an effort to further streamline our operations and increase margins, we moved a number of our daily functions to our Malaysian campus which we anticipate will reduce our operating expenses by $8 million annually. During this restructuring and manufacturing transitional period, we took a measured approach to revenue so that customers are not adversely affected by our internal change-over. Another milestone also was our reduction in accounts receivable which happened for the first time in Ispire's history. We took the necessary steps this quarter to focus on higher quality customers, including larger MSOs which helped bolster our overall financial position.\"\n\"We also received an interim license for manufacturing nicotin...